BriaCell Therapeutics Cor... (BCTX)
NASDAQ: BCTX
· Real-Time Price · USD
0.77
0.03 (4.05%)
At close: Aug 18, 2025, 3:59 PM
0.75
-2.47%
After-hours: Aug 18, 2025, 07:37 PM EDT
4.05% (1D)
| Bid | 0.74 |
| Market Cap | 13.5M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -19.43M |
| EPS (ttm) | -7.69 |
| PE Ratio (ttm) | -0.1 |
| Forward PE | -0.35 |
| Analyst | Buy |
| Ask | 0.76 |
| Volume | 613,277 |
| Avg. Volume (20D) | 1,295,801 |
| Open | 0.75 |
| Previous Close | 0.74 |
| Day's Range | 0.74 - 0.78 |
| 52-Week Range | 0.35 - 9.82 |
| Beta | 1.41 |
About BCTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BCTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BCTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-61.78%
BriaCell Therapeutics shares are trading lower aft...
Unlock content with
Pro Subscription
1 month ago
+0.69%
BCTX stock has given up its prior gain. BriaCell shares were trading higher after the company reported a 52% one-year survival rate in its Phase 2 metastatic breast cancer trial.
